• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

片段库设计、合成与扩展:培育一个合成与训练平台。

Fragment library design, synthesis and expansion: nurturing a synthesis and training platform.

作者信息

Ray Peter C, Kiczun Michael, Huggett Margaret, Lim Andrew, Prati Federica, Gilbert Ian H, Wyatt Paul G

机构信息

Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, Scotland, UK.

Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, Scotland, UK.

出版信息

Drug Discov Today. 2017 Jan;22(1):43-56. doi: 10.1016/j.drudis.2016.10.005. Epub 2016 Oct 26.

DOI:10.1016/j.drudis.2016.10.005
PMID:27793744
Abstract

The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the identification of suitable chemical starting points for drug discovery programs. The physicochemical properties of molecules are crucial in determining the success of small molecules in clinical development, yet reports suggest that pharmaceutical and academic sectors often produce molecules with poor drug-like properties. We present a platform to design novel, high quality and diverse fragment- and lead-oriented libraries with appropriate physicochemical properties in a cost-efficient manner. This approach has the potential to assist the way libraries are constructed by significantly addressing the historical uneven exploration of chemical space for drug discovery. Additionally, this platform can teach undergraduates and graduates about compound library design.

摘要

获得合适的、多样化的面向片段和先导物的筛选化合物,是为药物发现项目确定合适化学起始点的关键。分子的物理化学性质对于小分子在临床开发中的成功起着至关重要的作用,但报告表明,制药和学术领域常常产出具有不良类药性质的分子。我们提出了一个平台,以经济高效的方式设计具有适当物理化学性质的新型、高质量且多样化的面向片段和先导物的文库。这种方法有可能显著解决药物发现中化学空间探索历史上的不均衡问题,从而有助于文库的构建方式。此外,该平台可以向本科生和研究生传授化合物文库设计知识。

相似文献

1
Fragment library design, synthesis and expansion: nurturing a synthesis and training platform.片段库设计、合成与扩展:培育一个合成与训练平台。
Drug Discov Today. 2017 Jan;22(1):43-56. doi: 10.1016/j.drudis.2016.10.005. Epub 2016 Oct 26.
2
Developing a drug-like natural product library.开发一个类药物天然产物库。
J Nat Prod. 2008 Mar;71(3):464-8. doi: 10.1021/np070526y. Epub 2008 Feb 8.
3
On the origins of three-dimensionality in drug-like molecules.关于类药物分子三维结构的起源
Future Med Chem. 2016 Sep;8(14):1753-67. doi: 10.4155/fmc-2016-0095. Epub 2016 Aug 30.
4
Efficient exploration of chemical space by fragment-based screening.基于片段筛选的化学空间高效探索
Prog Biophys Mol Biol. 2014 Nov-Dec;116(2-3):82-91. doi: 10.1016/j.pbiomolbio.2014.09.007. Epub 2014 Sep 28.
5
Biologically active metabolites in drug discovery.药物研发中的生物活性代谢物。
Bioorg Med Chem Lett. 2021 Sep 15;48:128255. doi: 10.1016/j.bmcl.2021.128255. Epub 2021 Jul 7.
6
A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.极简片段法设计天然产物类似物的合成支架。
Drug Discov Today. 2012 Nov;17(21-22):1170-4. doi: 10.1016/j.drudis.2012.05.013. Epub 2012 May 31.
7
From fragment screening to potent binders: strategies for fragment-to-lead evolution.从片段筛选到强效结合物:从片段到先导物进化的策略
Mini Rev Med Chem. 2009 Jul;9(8):956-61. doi: 10.2174/138955709788681645.
8
Structure-Based Drug Design Strategies and Challenges.基于结构的药物设计策略与挑战。
Curr Top Med Chem. 2018;18(12):998-1006. doi: 10.2174/1568026618666180813152921.
9
Crystallographic fragment screening.晶体学片段筛选
Methods Mol Biol. 2012;841:161-77. doi: 10.1007/978-1-61779-520-6_7.
10
Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.用于药物筛选的市售化合物库的类药性和疏水性增加。
Curr Top Med Chem. 2012;12(14):1500-13. doi: 10.2174/156802612802652466.

引用本文的文献

1
Advancing Target Validation and Ligandability Assessment: Fragment Screening via F NMR Spectroscopy.推进靶点验证和可配体性评估:通过核磁共振光谱法进行片段筛选。
Methods Mol Biol. 2025;2905:193-206. doi: 10.1007/978-1-0716-4418-8_13.
2
Design of the Global Health chemical diversity library v2 for screening against infectious diseases.全球健康化学多样性文库 v2 的设计,用于筛选传染病的药物。
PLoS Negl Trop Dis. 2023 Dec 27;17(12):e0011799. doi: 10.1371/journal.pntd.0011799. eCollection 2023 Dec.
3
Cheminformatics and artificial intelligence for accelerating agrochemical discovery.
用于加速农用化学品发现的化学信息学与人工智能
Front Chem. 2023 Nov 29;11:1292027. doi: 10.3389/fchem.2023.1292027. eCollection 2023.
4
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set.阿斯利康的片段筛选:开发下一代生物物理片段集。
RSC Med Chem. 2022 Jul 4;13(9):1052-1057. doi: 10.1039/d2md00154c. eCollection 2022 Sep 21.
5
Fragment Libraries Designed to Be Functionally Diverse Recover Protein Binding Information More Efficiently Than Standard Structurally Diverse Libraries.片段文库设计成具有功能多样性,比标准结构多样性文库更有效地回收蛋白质结合信息。
J Med Chem. 2022 Aug 25;65(16):11404-11413. doi: 10.1021/acs.jmedchem.2c01004. Epub 2022 Aug 12.
6
Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite.迈向化学空间的系统探索:构建分子性质诊断套件中的片段库模块。
Mol Divers. 2023 Jun;27(3):1459-1468. doi: 10.1007/s11030-022-10506-5. Epub 2022 Aug 4.
7
Emergent synthetic methods for the modular advancement of sp-rich fragments.用于富sp片段模块化推进的紧急合成方法。
Chem Sci. 2021 Mar 2;12(13):4646-4660. doi: 10.1039/d1sc00161b.
8
Fragment-based drug discovery: opportunities for organic synthesis.基于片段的药物发现:有机合成的机遇
RSC Med Chem. 2020 Dec 24;12(3):321-329. doi: 10.1039/d0md00375a.
9
Fragment Screening by NMR.NMR 技术的片段筛选
Methods Mol Biol. 2021;2263:247-270. doi: 10.1007/978-1-0716-1197-5_11.
10
Small Polar Hits against : Screening, Initial Hit Optimization, and Metabolomic Studies.针对小极性化合物的研究:筛选、初始活性化合物优化及代谢组学研究
ACS Omega. 2019 Nov 4;4(21):19199-19215. doi: 10.1021/acsomega.9b02507. eCollection 2019 Nov 19.